Neurogene Inc. (NASDAQ: NGNE)
$18.0350
+2.4450 ( +16.51% ) 360.5K
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.
Market Data
Open
$18.0350
Previous close
$15.5900
Volume
360.5K
Market cap
$231.59M
Day range
$14.6970 - $18.3980
52 week range
$12.4900 - $74.4900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Nov 21, 2024 |
| 10-q | Quarterly Reports | 80 | Nov 18, 2024 |
| 8-k | 8K-related | 15 | Nov 18, 2024 |
| 8-k | 8K-related | 15 | Nov 18, 2024 |
| nt | Quarterly Reports | 1 | Nov 14, 2024 |
| 8-k | 8K-related | 62 | Nov 12, 2024 |
| 8-k | 8K-related | 19 | Nov 04, 2024 |
| 8-k | 8K-related | 53 | Aug 09, 2024 |
| 10-q | Quarterly Reports | 78 | Aug 09, 2024 |
| 8-k | 8K-related | 15 | Aug 07, 2024 |